Browse by Clinical Topic:


Featured CME/CE Content:
 
neuroscienceCME Editors' Picks:



Can You Hear Me Now? Engaging Patients in Virtual Shared Decision-Making

Premiere Date: Monday, April 26, 2021

This activity offers CE credit for:

  1. Physicians (CME)
  2. Pharmacists (ACPE)
  3. ABIM (MOC)
  4. Other


All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Tuesday, April 26, 2022
Note: Credit Is No Longer Available

Faculty


Mintu P. Turakhia, MD, MASMintu P. Turakhia, MD, MAS (Moderator)
Associate Professor
Executive Director, Center for Digital Health
Stanford University School of Medicine
Director of Cardiac Electrophysiology
VA Palo Alto Health Care System
Palo Alto, CA

Geoffrey Barnes, MD, MScGeoffrey Barnes, MD, MSc 
Assistant Professor, Cardiovascular Medicine and Vascular Medicine
Department of Internal Medicine, Division of Cardiovascular Medicine
University of Michigan Health System
Ann Arbor, MI

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPLMargot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL 
Associate Professor
Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University
Philadelphia, PA

Statement of Need

Fewer than half of high-risk patients with atrial fibrillation (AF) receive recommended anticoagulation therapy for stroke prevention, and of those who start anticoagulation, 30% - 50% stop treatment within 12 months. Shared decision-making (SDM) can improve adherence to anticoagulant therapy and should be used to individualize anticoagulant therapy based on each patient's risk of stroke and bleeding and personal preferences.

The final installment of this CME Outfitters BriefCase series focuses on patient education and SDM when providing care via telemedicine, including use of digital decision aids and electronic resources to assist with SDM, developing individualized treatment plans, overcoming social health care disparities, building trust with patients in a virtual care setting, and reinforcing the importance of adherence and persistence to prescribed therapy.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Utilize digital decision aids for patient education and SDM when providing care via telemedicine.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Explain digital decision aids for patient education and SDM for care via telemedicine.

Financial Support

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Target Audience

Primary care physicians, cardiologists, PAs, nurse practitioners, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hours (0.075 CEUs) Universal Activity Number:
Enduring: JA0007185-0000-21-112-H01-P

Type: Knowledge-based

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Format
Enduring material

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs: PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Turakhia reports that he receives grants from the American Heart Association; Apple Inc.; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; Cardiva Medical, Inc.; Janssen Pharmaceuticals, Inc.; and SentreHEART, Inc. He is a consultant for Abbott; BIOTRONIK, Inc.; Cardiva Medical, Inc.; iRhythm Technologies, Inc.; Johnson & Johnson; Medtronic; Milestone Pharmaceuticals, Inc.; MyoKardia, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi. He receives other financial or material support as an editor for JAMA Cardiology.

Dr. Barnes reports that he receives grants from the Agency for Healthcare Research and Quality (AHRQ); Blue Cross Blue Shield of Michigan; and National Heart, Lung, and Blood Institute (NHLBI). He is a consultant for Acelis Connected Health, AMAG Pharmaceuticals; Bristol Myers Squibb and Pfizer Alliance; and Janssen Pharmaceuticals, Inc. He receives other financial or material support as a member of the Board of Directors - Anticoagulation Forum and National Certification Board of Anticoagulation Providers.

Dr. Savoy has no disclosures to report.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

BC-036-042621-90

Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download